IRIS Accounts Production v22.2.0.402 11151441 director 1.2.21 31.1.22 31.1.22 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure111514412021-01-31111514412022-01-31111514412021-02-012022-01-31111514412020-01-31111514412020-02-012021-01-31111514412021-01-3111151441ns16:EnglandWales2021-02-012022-01-3111151441ns15:PoundSterling2021-02-012022-01-3111151441ns11:Director12021-02-012022-01-3111151441ns11:PrivateLimitedCompanyLtd2021-02-012022-01-3111151441ns11:SmallEntities2021-02-012022-01-3111151441ns11:AuditExempt-NoAccountantsReport2021-02-012022-01-3111151441ns11:SmallCompaniesRegimeForDirectorsReport2021-02-012022-01-3111151441ns11:SmallCompaniesRegimeForAccounts2021-02-012022-01-3111151441ns11:FullAccounts2021-02-012022-01-3111151441ns6:CurrentFinancialInstruments2022-01-3111151441ns6:CurrentFinancialInstruments2021-01-3111151441ns6:ShareCapital2022-01-3111151441ns6:ShareCapital2021-01-3111151441ns6:RetainedEarningsAccumulatedLosses2022-01-3111151441ns6:RetainedEarningsAccumulatedLosses2021-01-3111151441ns11:RegisteredOffice2021-02-012022-01-3111151441ns6:PlantMachinery2021-01-3111151441ns6:PlantMachinery2021-02-012022-01-3111151441ns6:PlantMachinery2022-01-3111151441ns6:PlantMachinery2021-01-31
REGISTERED NUMBER: 11151441 (England and Wales)















Report of the Director and

Unaudited Financial Statements for the Year Ended 31 January 2022

for

Dartpharma Quality Services Ltd

Dartpharma Quality Services Ltd (Registered number: 11151441)






Contents of the Financial Statements
for the Year Ended 31 January 2022




Page

Report of the Director 1

Balance Sheet 2

Notes to the Financial Statements 4


Dartpharma Quality Services Ltd (Registered number: 11151441)

Report of the Director
for the Year Ended 31 January 2022

The director presents his report with the financial statements of the company for the year ended 31 January 2022.

DIRECTOR
Mr K Mackenzie held office during the whole of the period from 1 February 2021 to the date of this report.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Mr K Mackenzie - Director


9 September 2022

Dartpharma Quality Services Ltd (Registered number: 11151441)

Balance Sheet
31 January 2022

31.1.22 31.1.21
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 337 447

CURRENT ASSETS
Cash at bank 83,237 77,032

CREDITORS
Amounts falling due within one year 5 8,881 9,843
NET CURRENT ASSETS 74,356 67,189
TOTAL ASSETS LESS CURRENT
LIABILITIES

74,693

67,636

PROVISIONS FOR LIABILITIES 64 85
NET ASSETS 74,629 67,551

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 74,529 67,451
74,629 67,551

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dartpharma Quality Services Ltd (Registered number: 11151441)

Balance Sheet - continued
31 January 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 9 September 2022 and were signed by:





Mr K Mackenzie - Director


Dartpharma Quality Services Ltd (Registered number: 11151441)

Notes to the Financial Statements
for the Year Ended 31 January 2022

1. STATUTORY INFORMATION

Dartpharma Quality Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11151441

Registered office: 9 Palmers Avenue
Grays
Essex
RM17 5TX

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Dartpharma Quality Services Ltd (Registered number: 11151441)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2022

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2021 - 1 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 February 2021
and 31 January 2022 552
DEPRECIATION
At 1 February 2021 105
Charge for year 110
At 31 January 2022 215
NET BOOK VALUE
At 31 January 2022 337
At 31 January 2021 447

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.22 31.1.21
£    £   
Taxation and social security 2,373 3,194
Other creditors 6,508 6,649
8,881 9,843